Navigation Links
Presentations From Recent Heart Rhythm Society Meeting Validate the Safety and Efficacy of Ablation Frontiers Technology in 230 Patients
Date:5/23/2008

lation Frontiers system. These presentations demonstrated a 100 percent acute success rate, no peri/post-procedure complications up to 7 days, and procedure time of 85 +/- 33 minutes. Of those patients monitored at the 6 month follow-up date, 83 percent were free of AF and off anti-arrhythmic drugs.

A smaller study of 20 patients with permanent AF was presented by Dr. Gregory Michaud, Director of the Center for the Advanced Management of Atrial Fibrillation at the Brigham and Women's Hospital in Boston. This data represented procedures performed by 12 first-time operators as part of the feasibility phase of a US clinical trial called TTOP-AF, or the Tailored Treatment of Permanent AF, which is currently enrolling patients. Dr. Michaud reported that 96 percent of patients experienced a procedural success rate with no complications reported. At 6 months follow up, 75 percent of patients were in sinus rhythm, free of AF. After receiving early data from this group of patients, the Food and Drug Administration (FDA) allowed commencement of the pivotal TTOP-AF trial in the US.

"These early reports are extremely promising," noted Dr. Boersma, "and we are hopeful that long-term data will maintain consistency with the results presented. As physicians, we are excited about the remarkably close alignment of these safety and efficacy outcomes, with greatly reduced procedure times, in both the paroxysmal and permanent AF populations."

Atrial Fibrillation is a common and devastating cardiac rhythm disorder in which the heart's upper chambers beat in an extremely fast and chaotic rhythm. Symptoms may include palpitations, dizziness and shortness of breath. AF can present in different forms including paroxysmal, in which the abnormal rhythm starts and stops on its own, or permanent, which does not stop on its own and cannot be stopped with currently available medical treatments (drugs or cardioversion). Left untreated, AF patients are at an increased risk for s
'/>"/>

SOURCE Ablation Frontiers, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
2. Threshold to Host Conference Call to Discuss Results From Clinical Presentations at European Cancer Conference (ECCO)
3. IDM Pharma Announces Upcoming Clinical Data Presentations
4. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
5. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
6. CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting
7. TargeGen Announces Planned Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients, and Presentations at ASH
8. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
9. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR Annual Meeting
10. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
11. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... SHANGHAI , Sept. 22, 2014 ... global knowledge leader in healthcare technology, media and ... healthcare innovation in China ... technologies. Continua and BHG announced this new partnership ... this week in Washington, DC ...
(Date:9/22/2014)... -- Research and Markets has announced ... (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - ... On the basis of type ... been divided into eight major segments, namely, light/laser, ... ablation technologies. The light/laser ablation technology segment accounted ...
(Date:9/22/2014)... , Sept. 22, 2014  Olympus, a global ... for medical and surgical procedures, among other core ... with Munich -based Brainlab to ... Navigation. This agreement applies to the US ... U.S. sales and all distribution outside the U.S. ...
Breaking Medicine Technology:Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 4
... June 22, 2011 Life Technologies Corporation ... that the company has led a successful consortium ... the Oxford NIHR Biomedical Research Centre, AstraZeneca, and ... Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ...
... June 22, 2011 Reportlinker.com announces that ... in its catalogue: U.S. ... http://www.reportlinker.com/p0559270/US-Urinary-Incontinence-Devices.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Food_Ingredient This research ... incontinence device market. The urinary incontinence device ...
Cached Medicine Technology:Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients in the U.K. 2Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients in the U.K. 3Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients in the U.K. 4Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients in the U.K. 5Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients in the U.K. 6Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients in the U.K. 7Reportlinker Adds U.S. Urinary Incontinence Devices 2Reportlinker Adds U.S. Urinary Incontinence Devices 3Reportlinker Adds U.S. Urinary Incontinence Devices 4
(Date:9/22/2014)... September 19, 2014 -- Recent two-generation approaches to ... are receiving increasing attention from researchers, advocates, and ... to enable them to move to jobs that ... early care and education for children, these programs ... However, according to a new report from ...
(Date:9/22/2014)... RESTON, Va. (PRWEB) September 22, 2014 ... (WEDI), the nation’s leading nonprofit authority on ... in healthcare information exchange, announced findings from its ... unique Health Plan Identifier (HPID) within electronic transactions ... Act (HIPAA). WEDI conducted the survey from August ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. 22, ... What can I do to help ensure a healthy baby? ... may play a role in reducing the risk of having ... found that mothers of children with autism were significantly less ... than those whose children seem to be developing normally. ...
(Date:9/22/2014)... 2014 Severe weather can occur with little warning, ... as part of National Preparedness Month, Amica Insurance is ... for the unexpected:, , Build an emergency supply ... and one gallon of water per person per day for at ... plan that includes pets so your family knows what to do ...
(Date:9/22/2014)... The struggles that lie in communication between ... been well-documented—reportedly, language barriers between doctors and patients are ... room and an increased likelihood for fatal consequences and ... the largest medical facility in the Fargo, ND and ... the need for Video Remote Interpreting (VRI), ...
Breaking Medicine News(10 mins):Health News:A two-generation lens: Current state policies fail to support families with young children 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 3Health News:Could Low Iron Intake During Pregnancy Raise Autism Risk? 2Health News:Could Low Iron Intake During Pregnancy Raise Autism Risk? 3Health News:Amica Shares Tips for National Preparedness Month 2Health News:Healthcare Cost Savings Case Study:Stratus Video Interpreting Assists Sanford Health System in Accommodating Increasing LEP Population,Saves a Predicted $100,000 Per Year 2Health News:Healthcare Cost Savings Case Study:Stratus Video Interpreting Assists Sanford Health System in Accommodating Increasing LEP Population,Saves a Predicted $100,000 Per Year 3Health News:Healthcare Cost Savings Case Study:Stratus Video Interpreting Assists Sanford Health System in Accommodating Increasing LEP Population,Saves a Predicted $100,000 Per Year 4
... LONDON: Children who attend day care or play groups ... most common type of childhood leukaemia than those who ... investigating the link. , The new research, to ... Causes and Prevention of Childhood Leukaemia Conference in London, ...
... Retire from Company -, LAVAL, QC, April ... today announced that Claire Brulle, M.D. has been ... Company. Incumbent,Chief Medical Officer Dr. Sylvie Bouchard has ... practicing medicine., "Dr. Brulle brings to Labopharm ...
... Authentidate,Holding Corp. (Nasdaq: ADAT ), ... and web-based services, today announced that United,Seating ... providers of comprehensive,seating and mobility solutions for ... platform from Authentidate(R) to facilitate its,mobility provisioning ...
... TRIANGLE PARK, N.C., April 28 Tryton Medical,Inc. ... Davis as President and,Chief Executive Officer. Founded in ... that are designed to definitively treat bifurcation,lesions., ... 20-year career with,Guidant and Eli Lilly & Company. ...
... (Oakland, Calif.) Diabetes before motherhood more than doubled ... to a Kaiser Permanente study published in the May ... previous studies have looked exclusively at gestational diabetes (diabetes ... baby is born), this is the largest and most ...
... the Universities of Exeter and Coventry have developed the ... the rapid diagnostic tests (RDTs) currently used in the ... suggest that the technique could be as effective as ... potentially viable alternative. The team is now working on ...
Cached Medicine News:Health News:New analysis finds daycare attendance early in life cuts childhood leukemia risk by 30 percent 2Health News:New analysis finds daycare attendance early in life cuts childhood leukemia risk by 30 percent 3Health News:Labopharm Appoints Dr. Claire Brulle as Senior Vice-President and Chief Medical Officer 2Health News:Leading Provider United Seating & Mobility Implements Authentidate's Inscrybe Healthcare Platform to Standardize and Streamline Administrative Processes 2Health News:Leading Provider United Seating & Mobility Implements Authentidate's Inscrybe Healthcare Platform to Standardize and Streamline Administrative Processes 3Health News:Leading Provider United Seating & Mobility Implements Authentidate's Inscrybe Healthcare Platform to Standardize and Streamline Administrative Processes 4Health News:J. Greg Davis Appointed President & Chief Executive Officer of Tryton Medical, Inc. 2Health News:Kaiser Permanente study finds diabetes doubling before motherhood 2Health News:Kaiser Permanente study finds diabetes doubling before motherhood 3Health News:Exeter engineers create new technique for malaria diagnosis 2